Search results

• Methamphetamine
  76 (8): 1169–1174. ISSN 0002-838X.  https://en.wikipedia.org/wiki/Monoamine_releasing_agent#Activity_profiles Kirkpatrick, M. G., Gunderson, E. W., Johanson
  41 KB (5,798 words) - 13:29, 16 April 2024
• 4-FA
  fluorinated analogue of amphetamine. 4-Fluoroamphetamine acts as a releasing agent and reuptake inhibitor of dopamine, serotonin, and norepinephrine producing
  21 KB (3,439 words) - 15:42, 30 July 2022
• Research chemicals
  drugs such as MAOIs, RIMAs, stimulants and any substance which act as a releasing agent or reuptake inhibitor of neurotransmitters such as serotonin and dopamine
  19 KB (2,209 words) - 23:08, 21 April 2024
• Main Page (section Please don't crawl the wiki. Use our API instead.PsychonautWiki ❤️ Developers. Please report any obstacles.)
  Opioid ⋅ Phenethylamine ⋅ Research chemicals ⋅ Reuptake inhibitor ⋅ Releasing agent ⋅ Substituted amphetamine ⋅ Substituted cathinone ⋅ Substituted pyrrolidine
  21 KB (1,004 words) - 23:38, 13 May 2024
• 6-APB
  (SERT), respectively. 6-APB also possesses additional activity as a releasing agent of these monoamine neurotransmitters. 6-APB is a potent full agonist
  33 KB (4,870 words) - 14:34, 16 April 2024
• MDMA
  methylated analog of the hemostatic agent hydrastinine. There are no indications of interest in MDMA as an active agent itself. It was not mentioned again
  85 KB (10,499 words) - 14:24, 16 April 2024
• 4-FMA
  structural analog 4-FA, 4-Fluoromethamphetamine is thought to act as a releasing agent and reuptake inhibitor of dopamine, serotonin, and norepinephrine, producing
  21 KB (3,467 words) - 16:14, 30 July 2022
• 3-MeO-PCP
  MDMA: 3-MeO-PCP acts as a mild serotonin releasing agent and could interact negatively with the serotonin release of MDMA Austria: 3-MeO-PCP is illegal to
  25 KB (3,520 words) - 21:44, 6 May 2024
• Stimulants
  signalling act as reuptake inhibitors (NDRIs, e.g. methylphenidate), releasing agents (NDRAs, e.g. amphetamine) or receptor ligands (e.g yohimbine). Stimulants
  11 KB (1,055 words) - 02:52, 12 May 2024
• Amphetamine
  Additionally, it sees widespread illicit use as a performance enhancing agent and recreational substance. Subjective effects include stimulation, focus
  41 KB (5,610 words) - 19:01, 7 April 2024
• MDA
  primarily as a serotonin-norepinephrine-dopamine reuptake inhibitor and releasing agent.[citation needed] However, MDA is significantly more potent by weight
  31 KB (4,379 words) - 12:23, 6 May 2024
• ΑMT
  psychedelic αMT acts as a relatively balanced reuptake inhibitor and releasing agent of the main three monoamines; serotonin, norepinephrine, and dopamine
  25 KB (2,825 words) - 16:14, 28 November 2022
• MDAI
  acts as a putatively non-neurotoxic and highly selective serotonin releasing agent (SSRA) with neglible effects on dopamine and norepinephrine. MDAI was
  17 KB (2,560 words) - 07:40, 12 October 2023
• Tramadol
  noradrenaline reuptake. Tramadol acts as an opioid receptor agonist, serotonin releasing agent, norepinephrine reuptake inhibitor, NMDA receptor antagonist, 5-HT2C
  22 KB (3,211 words) - 19:11, 7 April 2024
• 6-APDB
  this furan ring with 5-APDB, 5-MAPDB and 6-MAPDB. 6-APDB acts as a releasing agent and triple reuptake inhibitor of the monoamine neurotransmitters known
  26 KB (4,015 words) - 23:44, 21 April 2024
• Cyclazodone
  function. There is no evidence that releasing agents are directly neurotoxic in humans. However, large doses of releasing agents may cause indirect neurotoxicity
  19 KB (2,675 words) - 16:54, 31 March 2024
• Methylphenidate
  methylphenidate is a dopamine reuptake inhibitor while amphetamine is both a releasing agent and reuptake inhibitor of dopamine and norepinephrine. Each of these
  31 KB (4,254 words) - 15:15, 6 May 2024
• Nicotine
  widely used substances in the world. It is also used as an antiherbivore agent to deter plant predation and has been used as an insecticide in the past
  53 KB (5,335 words) - 06:57, 15 May 2024
• Barbiturates
  explain the superior CNS-depressant effects of these agents to alternative GABA potentiating agents such as benzodiazepines and quinazolinones. At higher
  16 KB (1,815 words) - 09:25, 14 January 2023
• Methylone
  with MDA, MDAI and MDMA. Methylone acts as a mixed reuptake inhibitor/releasing agent of serotonin, norepinephrine, and dopamine. These neurotransmitters
  19 KB (2,841 words) - 14:21, 16 April 2024
• Ayahuasca
  sometimes medicinal, psychedelic effects. The co-consumption of an MAOI agent is necessary for the combination to work, as the DMT molecule (which is a
  33 KB (3,884 words) - 07:33, 16 November 2023
• Clonidine
  clonidine first saw clinical use in 1966. As the first anti-hypertensive agent with a clearly identifiable central site of action, clonidine has been an
  22 KB (2,932 words) - 13:49, 16 April 2024
• Aniracetam
  Referan, and systematically as N-anisoyl-2-pyrrolidinone) is a nootropic agent belonging to the racetam family of drugs. Although it is one of the first
  11 KB (1,427 words) - 22:01, 24 January 2024
• 2-FA
  it most likely acts primarily as both a dopamine and norepinephrine releasing agent. This means it effectively increases the levels of the norepinephrine
  17 KB (3,024 words) - 17:25, 18 January 2024
• Bufotenin
  with MAOIs, RIMAs, SSRIs, stimulants or any substance which acts as a releasing agent or reuptake inhibitor of monoamine neurotransmitters. Disclaimer: The
  16 KB (2,273 words) - 19:54, 7 April 2024
• MDEA
  ring with other entactogens like MDMA, MDA and MDAI. MDEA acts as a releasing agent and reuptake inhibitor of the monoamine neurotransmitters serotonin
  25 KB (3,654 words) - 23:46, 21 April 2024
• Ephenidine
  com/science/article/pii/S0378427415300333. “Ephenidine: A New Psychoactive Agent with Ketamine-like NMDA Receptor Antagonist Properties.” Neuropharmacology
  25 KB (3,096 words) - 09:43, 10 May 2024
• Scientific information
  content listed within this portal. Agonist Antagonist Reuptake inhibitor Releasing agent Inverse agonist Positive allosteric modulator Negative allosteric modulator
  599 bytes (162 words) - 23:00, 21 April 2024
• Memantine
  Memantine was first synthesized by Eli Lilly and Company in 1968 as a potential agent to treat diabetes.[citation needed] Memantine is classified as an NMDA receptor
  17 KB (2,270 words) - 05:20, 1 May 2024
• 3-FEA
  dopamine, norepinephrine, and serotonin in the brain by acting as a releasing agent of said neurotransmitters and/or by binding to and partially blocking
  19 KB (3,317 words) - 15:23, 30 July 2022
• Alcohol
  In the past, alcohol was believed to be a non-specific pharmacological agent affecting many neurotransmitter systems in the brain. Although this notion
  95 KB (11,688 words) - 02:47, 12 May 2024
• Mephedrone
  ring. Given its chemical structure, mephedrone is likely to act as a releasing agent and a reuptake inhibitor for monoamine neurotransmitters such as dopamine
  29 KB (3,963 words) - 14:23, 16 April 2024
• 2-FEA
  that it releases the neurotransmitters: serotonin, dopamine, and norepinephrine. 2-FEA likely creates it effects by acting as a releasing agent of said
  13 KB (1,917 words) - 18:16, 30 April 2024
• 3-FMA
  substitutions at similar positions, it most likely acts primarily as a triple releasing agent of serotonin, dopamine, and norepinephrine.[citation needed] Disclaimer:
  14 KB (2,687 words) - 15:28, 30 July 2022
• 3-FPM
  consumed. Its mechanism of action appears to function by acting as a releasing agent for dopamine and norepinephrine, increasing their concentrations in
  15 KB (2,265 words) - 06:42, 8 September 2023
• 3-FA
  it most likely acts primarily as both a dopamine and norepinephrine releasing agent, with modest selectivity for serotonin. This means it effectively increases
  15 KB (2,726 words) - 11:39, 17 February 2024
• Modafinil
  which have fatigue as a symptom. Modafinil has also been used as a doping agent by various athletes due to its ability to produce physical stimulation. It
  19 KB (3,104 words) - 11:29, 16 April 2024
• 5-MAPB
  speculated that 5-MAPB acts as a releasing agent for the previously mentioned neurotransmitters. As a result, releasing agents such as 5-MAPB may exert their
  13 KB (2,233 words) - 00:32, 31 December 2022
• GHB
  so-called "rebound" effect reported by individuals using GHB as a sleeping agent wherein they awake suddenly after several hours of GHB-induced deep sleep
  35 KB (4,460 words) - 13:32, 16 April 2024
• Melatonin
  Acuña-Castroviejo, D., Camello, P. J. (2010). "Melatonin, a potential therapeutic agent for smooth muscle-related pathological conditions and aging". Current Medicinal
  15 KB (1,896 words) - 23:12, 21 April 2024
• NEP
  may also be due to its activity as a serotonin reuptake inhibitor or releasing agent in moderate to high doses, although new research has shown very low
  18 KB (2,677 words) - 06:56, 28 April 2024
• Phenylpiracetam
  Phenotropil and Carphedon) is a central nervous system stimulant and nootropic agent belonging to the racetam family of drugs. Although it is one of the first
  11 KB (1,273 words) - 00:25, 6 May 2024
• Prolintane
  the preparation of prolintane for use as a mild CNS stimulant, wakefulness agent, and cessation aid for cocaine addiction. It has been marketed in Europe
  11 KB (1,751 words) - 20:42, 12 September 2022
• Oxiracetam
  Oxiracetam (ISF 2522) is a mild central nervous system stimulant and nootropic agent belonging to the racetam family of drugs. Although it is one of the first
  9 KB (1,148 words) - 19:58, 2 August 2022
• 2C-T-2 (category PsychonautWiki articles needing factual verification from October 2020)
  literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of
  22 KB (2,627 words) - 23:08, 29 May 2021
• N-Acetylcysteine
  as a dietary supplement. N-Acetylcysteine (NAC) is emerging as a useful agent in the treatment of psychiatric disorders. It is currently being explored
  17 KB (1,957 words) - 17:42, 7 April 2024
• Myristicin
  5-Methoxylicarin A) have been shown to act as endo-cannabinoid modulating agents by inhibiting the enzymes FAAH and MAGL. In comparison to datura or diphenhydramine
  19 KB (2,523 words) - 07:09, 16 November 2023
• Psilocin
  component is however much less common and intense than it is with serotonin releasing agents such as MDMA. Watery eyes Muscle contractions Olfactory hallucination
  40 KB (4,715 words) - 16:45, 25 January 2024
• PMMA
  Methamphetamine. PMMA, like PMA most likely acts as a selective serotonin releasing agent (SSRA) with weak effects on dopamine and norepinephrine transporters
  10 KB (1,254 words) - 09:30, 28 December 2022
• Pregabalin
  Federation of Neurological Societies recommends pregabalin as a first line agent for the treatment of pain associated with diabetic neuropathy, post-herpetic
  41 KB (5,211 words) - 12:50, 15 March 2024

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)